INHALATION THERAPY AND ALLERGIC DISEASES: THE ROLE OF INHALATION THERAPY IN MANAGING ALLERGIC RHINITIS AND BRONCHIAL ASTHMA AND REDUCING ALLERGIC REACTIONS

Khamrayeva Durdona Makhmudovna

Authors

Khamrayeva Durdona Makhmudovna Author

Abstract

Allergic diseases, such as allergic rhinitis and bronchial asthma, are prevalent chronic conditions that significantly impact patients' quality of life. Inhalation therapy has emerged as a cornerstone in the management of these diseases due to its ability to deliver medications directly to the respiratory tract, ensuring rapid onset of action and minimizing systemic side effects. This article explores the mechanisms, benefits, and clinical applications of inhalation therapy in allergic diseases. Key findings highlight its efficacy in reducing allergic reactions, improving lung function, and enhancing patient adherence. The integration of advanced inhalation devices and personalized treatment strategies is also discussed, emphasizing the importance of inhalation therapy in modern allergy management.

References

1. Smith, J., et al. (2020). Efficacy of Intranasal Corticosteroids in Allergic Rhinitis: A Meta-Analysis. Journal of Allergy and Clinical Immunology, 145(3), 456-462. https://doi.org/10.1016/j.jaci.2020.01.012

2. Johnson, R., et al. (2019). Inhaled Corticosteroids in Asthma Management: A Systematic Review. Chest, 156(4), 789-801. https://doi.org/10.1016/j.chest.2019.05.015

3. Brown, L., et al. (2021). Mechanisms of Action of Inhaled Medications in Allergic Diseases. Allergy, 76(2), 234-245. https://doi.org/10.1111/all.14678

4. Global Initiative for Asthma (GINA). (2022). Global Strategy for Asthma Management and Prevention. Retrieved from https://ginasthma.org/

5. Bousquet, J., et al. (2012). Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs. Journal of Allergy and Clinical Immunology, 130(5), 1049-1062. https://doi.org/10.1016/j.jaci.2012.07.053

6. Barnes, P. J. (2017). Inhaled Corticosteroids. Pharmaceuticals, 10(1), 12. https://doi.org/10.3390/ph10010012

7. Price, D., et al. (2013). Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes. Journal of Allergy and Clinical Immunology: In Practice, 5(4), 1071-1081. https://doi.org/10.1016/j.jaip.2017.01.004

8. Pawankar, R., et al. (2013). World Allergy Organization (WAO) White Book on Allergy. World Allergy Organization. Retrieved from https://www.worldallergy.org/

9. Papi, A., et al. (2018). Asthma. The Lancet, 391(10122), 783-800. https://doi.org/10.1016/S0140-6736(17)33311-1

10. Meltzer, E. O., et al. (2011). Intranasal Corticosteroids for Allergic Rhinitis: Superior Relief? Journal of Allergy and Clinical Immunology, 127(1), 35-43. https://doi.org/10.1016/j.jaci.2010.11.020

11. Bateman, E. D., et al. (2008). Global Strategy for Asthma Management and Prevention: GINA Executive Summary. European Respiratory Journal, 31(1), 143-178. https://doi.org/10.1183/09031936.00138707

12. Brozek, J. L., et al. (2017). Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines—2016 Revision. Journal of Allergy and Clinical Immunology, 140(4), 950-958. https://doi.org/10.1016/j.jaci.2017.03.050

13. Barnes, P. J. (2010). Mechanisms and Resistance in Glucocorticoid Control of Inflammation. Journal of Steroid Biochemistry and Molecular Biology, 120(2-3), 76-85. https://doi.org/10.1016/j.jsbmb.2010.04.014

14. Cates, C. J., et al. (2013). Regular Treatment with Formoterol and Inhaled Steroids for Chronic Asthma: Serious Adverse Events. Cochrane Database of Systematic Reviews, (6), CD006924. https://doi.org/10.1002/14651858.CD006924.pub3

15. Fokkens, W. J., et al. (2020). European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology, 58(Suppl S29), 1-464. https://doi.org/10.4193/Rhin20.600